{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:19:17Z","timestamp":1785932357459,"version":"3.56.0"},"reference-count":256,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.niox.2018.04.010","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T05:12:37Z","timestamp":1525151557000},"page":"75-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["The nitric oxide-guanylate cyclase pathway and glaucoma"],"prefix":"10.1016","volume":"77","author":[{"given":"Lauren K.","family":"Wareham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel S.","family":"Buys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3136-9631","authenticated-orcid":false,"given":"Rebecca M.","family":"Sappington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2018.04.010_bib1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.niox.2018.04.010_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib3","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.preteyeres.2012.07.001","article-title":"Critical pathogenic events underlying progression of neurodegeneration in glaucoma","volume":"31","author":"Calkins","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib4","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Hussein M and early manifest glaucoma trial G. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib5","doi-asserted-by":"crossref","first-page":"327326","DOI":"10.1155\/2012\/327326","article-title":"Visual field loss morphology in high- and normal-tension glaucoma","volume":"2012","author":"Iester","year":"2012","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ICU.0b013e3282f3919b","article-title":"Normal-tension glaucoma: is it different from primary open-angle glaucoma?","volume":"19","author":"Shields","year":"2008","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib7","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","article-title":"Predictors of long-term progression in the early manifest glaucoma trial","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.niox.2018.04.010_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40123-017-0094-6","article-title":"Review of nitric oxide for the treatment of glaucomatous disease","volume":"6","author":"Aliancy","year":"2017","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.niox.2018.04.010_bib9","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.niox.2018.04.010_bib10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archopht.1981.03930010635009","article-title":"Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage","volume":"99","author":"Quigley","year":"1981","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib11","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.ophtha.2010.12.035","article-title":"Evaluation of retinal nerve fiber layer progression in glaucoma a prospective analysis with neuroretinal rim and visual field progression","volume":"118","author":"Leung","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.niox.2018.04.010_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/02713689608997407","article-title":"Correlation between the progression of optic disc and visual field changes in glaucoma","volume":"15","author":"Miglior","year":"1996","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1755-3768.1993.tb04989.x","article-title":"Elevated intraocular pressure and pseudoexfoliation of the lens capsule as risk factors for chronic open-angle glaucoma. A population-based five-year follow-up study","volume":"71","author":"Ekstrom","year":"1993","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0002-9394(14)70632-4","article-title":"Comparison of methods to evaluate the optic nerve head and nerve fiber layer for glaucomatous change","volume":"121","author":"Caprioli","year":"1996","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib16","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.ophtha.2009.06.042","article-title":"Natural history of open-angle glaucoma","volume":"116","author":"Heijl","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.niox.2018.04.010_bib17","first-page":"3460","article-title":"Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats","volume":"41","author":"Quigley","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archopht.1982.01030030137016","article-title":"Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy","volume":"100","author":"Quigley","year":"1982","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9394(01)00912-6","article-title":"Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma","volume":"132","author":"Kwon","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1874364101004010052","article-title":"Aqueous humor dynamics: a review","volume":"4","author":"Goel","year":"2010","journal-title":"Open Ophthalmol. J."},{"key":"10.1016\/j.niox.2018.04.010_bib22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.exer.2008.12.012","article-title":"Uveoscleral outflow\u2013a review","volume":"88","author":"Alm","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.exer.2016.01.017","article-title":"Unconventional aqueous humor outflow: a review","volume":"158","author":"Johnson","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib24","first-page":"911","article-title":"The aqueous humor drainage mechanism in the cynomolgus monkey (Macaca irus) with evidence for unconventional routes","volume":"4","author":"Bill","year":"1965","journal-title":"Invest. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib25","first-page":"920","article-title":"Production and drainage of aqueous humor in the cynomolgus monkey (Macaca irus)","volume":"4","author":"Bill","year":"1965","journal-title":"Invest. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-4835(66)80020-9","article-title":"The routes for bulk drainage of aqueous humour in the vervet monkey (Cercopithecus ethiops)","volume":"5","author":"Bill","year":"1966","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-4835(66)80019-2","article-title":"Conventional and uveo-scleral drainage of aqueous humour in the cynomolgus monkey (Macaca irus) at normal and high intraocular pressures","volume":"5","author":"Bill","year":"1966","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajo.2016.11.020","article-title":"Bimatoprost sustained-release implants for glaucoma therapy: 6-month results from a phase I\/II clinical trial","volume":"175","author":"Lewis","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib29","doi-asserted-by":"crossref","first-page":"P112","DOI":"10.1016\/j.ophtha.2015.10.055","article-title":"Primary open-angle glaucoma suspect preferred practice pattern((R)) guidelines","volume":"123","author":"Prum","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.niox.2018.04.010_bib30","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ophtha.2011.11.003","article-title":"Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement","volume":"119","author":"Chang","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.niox.2018.04.010_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ajo.2010.09.026","article-title":"A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study","volume":"151","author":"Krupin","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib32","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ophtha.2007.10.004","article-title":"Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines","volume":"115","author":"Stewart","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.niox.2018.04.010_bib33","article-title":"Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma","volume":"5","author":"Semba","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.niox.2018.04.010_bib34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archophthalmol.2009.9","article-title":"Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review","volume":"127","author":"Saylor","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib35","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor","volume":"327","author":"Palmer","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.niox.2018.04.010_bib36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.niox.2018.04.010_bib37","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1039\/c2cs15273h","article-title":"Nitric oxide release: part II. Therapeutic applications","volume":"41","author":"Carpenter","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.niox.2018.04.010_bib38","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10038","article-title":"Nitric oxide: the coming of the second messenger","volume":"2","author":"Murad","year":"2011","journal-title":"Rambam Maimonides Med. J."},{"key":"10.1016\/j.niox.2018.04.010_bib39","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/333664a0","article-title":"Vascular endothelial cells synthesize nitric oxide from L-arginine","volume":"333","author":"Palmer","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.niox.2018.04.010_bib40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0006-291X(89)80219-0","article-title":"A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells","volume":"158","author":"Palmer","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.niox.2018.04.010_bib41","doi-asserted-by":"crossref","first-page":"25218","DOI":"10.1074\/jbc.274.36.25218","article-title":"L-arginine binding to nitric-oxide synthase. The role of H-bonds to the nonreactive guanidinium nitrogens","volume":"274","author":"Babu","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2018.04.010_bib42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev.ph.57.030195.003423","article-title":"Nitric oxide synthases: properties and catalytic mechanism","volume":"57","author":"Griffith","year":"1995","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.niox.2018.04.010_bib43","first-page":"H1054","article-title":"VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells","volume":"274","author":"Hood","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.niox.2018.04.010_bib44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1006\/bbrc.1998.9719","article-title":"VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)","volume":"252","author":"Kroll","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.niox.2018.04.010_bib45","doi-asserted-by":"crossref","first-page":"C499","DOI":"10.1152\/ajpcell.00122.2003","article-title":"Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases","volume":"285","author":"Boo","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.niox.2018.04.010_bib46","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1167\/iovs.14-14515","article-title":"Nitric oxide (NO): an emerging target for the treatment of glaucoma","volume":"55","author":"Cavet","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"Pt 1","key":"10.1016\/j.niox.2018.04.010_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/bj3120169","article-title":"Inhibition of cytochrome c oxidase in turnover by nitric oxide: mechanism and implications for control of respiration","volume":"312","author":"Torres","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.niox.2018.04.010_bib48","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0092-8674(01)00495-0","article-title":"The prototypic redox-based signaling mechanism","volume":"106","author":"Stamler","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.niox.2018.04.010_bib49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/35055104","article-title":"Protein S-nitrosylation: a physiological signal for neuronal nitric oxide","volume":"3","author":"Jaffrey","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.niox.2018.04.010_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.pharmtox.41.1.203","article-title":"Novel effects of nitric oxide","volume":"41","author":"Davis","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.niox.2018.04.010_bib51","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1073\/pnas.86.13.5159","article-title":"Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase","volume":"86","author":"Knowles","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.niox.2018.04.010_bib52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0898-6568(02)00078-5","article-title":"Major occurrence of the new alpha2beta1 isoform of NO-sensitive guanylyl cyclase in brain","volume":"15","author":"Mergia","year":"2003","journal-title":"Cell. Signal."},{"key":"10.1016\/j.niox.2018.04.010_bib53","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI27657","article-title":"Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system","volume":"116","author":"Mergia","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.niox.2018.04.010_bib54","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1006\/bbrc.1999.1444","article-title":"Tissue distribution of the human soluble guanylate cyclases","volume":"263","author":"Budworth","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.niox.2018.04.010_bib55","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0165-6147(97)90687-8","article-title":"Soluble guanylate cyclase: the forgotten sibling","volume":"18","author":"Hobbs","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib56","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1073\/pnas.74.8.3203","article-title":"Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations","volume":"74","author":"Arnold","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.niox.2018.04.010_bib57","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMsa063904","article-title":"Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development","volume":"355","author":"Murad","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.niox.2018.04.010_bib58","first-page":"23","article-title":"Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine","volume":"3","author":"Katsuki","year":"1977","journal-title":"J. Cyclic. Nucl. Res."},{"key":"10.1016\/j.niox.2018.04.010_bib59","doi-asserted-by":"crossref","first-page":"10763","DOI":"10.1073\/pnas.190333697","article-title":"Human recombinant soluble guanylyl cyclase: expression, purification, and regulation","volume":"97","author":"Lee","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.niox.2018.04.010_bib60","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1432-1033.1990.tb15572.x","article-title":"Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method","volume":"190","author":"Humbert","year":"1990","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.niox.2018.04.010_bib61","doi-asserted-by":"crossref","first-page":"15104","DOI":"10.1074\/jbc.M710269200","article-title":"Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity","volume":"283","author":"Sharina","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2018.04.010_bib62","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.ne.19.030196.001315","article-title":"Structure and function of cyclic nucleotide-gated channels","volume":"19","author":"Zagotta","year":"1996","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.niox.2018.04.010_bib63","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/pr.110.002907","article-title":"cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action","volume":"62","author":"Francis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.niox.2018.04.010_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060156","article-title":"Soluble guanylate cyclase alpha1-deficient mice: a novel murine model for primary open angle glaucoma","volume":"8","author":"Buys","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.niox.2018.04.010_bib65","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1167\/iovs.08-2750","article-title":"Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork","volume":"50","author":"Ellis","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib66","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1017\/S0952523898155104","article-title":"Localization of nitric oxide synthase, NADPH diaphorase and soluble guanylyl cyclase in adult rabbit retina","volume":"15","author":"Haberecht","year":"1998","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.niox.2018.04.010_bib67","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1096\/fj.02-0359fje","article-title":"Visualization of gaseous monoxide reception by soluble guanylate cyclase in the rat retina","volume":"17","author":"Kajimura","year":"2003","journal-title":"Faseb. J."},{"key":"10.1016\/j.niox.2018.04.010_bib68","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S0952523898153075","article-title":"Functional localization of soluble guanylate cyclase in turtle retina: modulation of cGMP by nitric oxide donors","volume":"15","author":"Blute","year":"1998","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.niox.2018.04.010_bib69","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1002\/cne.23148","article-title":"Characterization of nitric oxide signaling pathways in the mouse retina","volume":"520","author":"Blom","year":"2012","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.niox.2018.04.010_bib70","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1167\/iovs.08-2750","article-title":"Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork","volume":"50","author":"Ellis","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib71","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0039-6257(97)84043-X","article-title":"Nitric oxide in the eye: multifaceted roles and diverse outcomes","volume":"42","author":"Becquet","year":"1997","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib72","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archopht.1997.01100150499009","article-title":"Nitric oxide synthase in the human glaucomatous optic nerve head","volume":"115","author":"Neufeld","year":"1997","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib73","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnmol.2014.00038","article-title":"Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma","volume":"7","author":"Buys","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.niox.2018.04.010_bib74","first-page":"1765","article-title":"Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye","volume":"36","author":"Nathanson","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib75","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1167\/iovs.07-1363","article-title":"Expression of nitrotyrosine and oxidative consequences in the trabecular meshwork of patients with primary open-angle glaucoma","volume":"49","author":"Fernandez-Durango","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib76","doi-asserted-by":"crossref","first-page":"C205","DOI":"10.1152\/ajpcell.00347.2014","article-title":"Role of nitric oxide in murine conventional outflow physiology","volume":"309","author":"Chang","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.niox.2018.04.010_bib77","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.1167\/iovs.14-14722","article-title":"Shear stress-triggered nitric oxide release from Schlemm's canal cells","volume":"55","author":"Ashpole","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib78","doi-asserted-by":"crossref","first-page":"9438","DOI":"10.1167\/iovs.11-7839","article-title":"eNOS, a pressure-dependent regulator of intraocular pressure","volume":"52","author":"Stamer","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib79","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1167\/iovs.15-16564","article-title":"Aqueous humor outflow physiology in NOS3 knockout mice","volume":"56","author":"Lei","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib80","first-page":"1710","article-title":"Peripheral endothelial dysfunction in normal pressure glaucoma","volume":"40","author":"Henry","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib81","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archophthalmol.2011.118","article-title":"Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with hypertension, alcohol intake, and cigarette smoking","volume":"129","author":"Kang","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib82","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1167\/iovs.09-4266","article-title":"Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with sex and postmenopausal hormone use","volume":"51","author":"Kang","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib83","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/IJG.0000000000000751","article-title":"The relation between endothelial nitric oxide synthase polymorphisms and normal tension glaucoma","volume":"26","author":"Jeoung","year":"2017","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.niox.2018.04.010_bib84","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.preteyeres.2007.01.004","article-title":"Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy","volume":"26","author":"Toda","year":"2007","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib85","first-page":"1774","article-title":"Alterations of ocular nitric oxide synthase in human glaucoma","volume":"36","author":"Nathanson","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib86","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0306-4522(93)90393-T","article-title":"The localization of nitric oxide synthase in the rat eye and related cranial ganglia","volume":"54","author":"Yamamoto","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.niox.2018.04.010_bib87","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1167\/iovs.13-13699","article-title":"The structure of the trabecular meshwork, its connections to the ciliary muscle, and the effect of pilocarpine on outflow facility in mice","volume":"55","author":"Overby","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib88","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/347768a0","article-title":"Localization of nitric oxide synthase indicating a neural role for nitric oxide","volume":"347","author":"Bredt","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.niox.2018.04.010_bib89","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1073\/pnas.90.9.4276","article-title":"Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation","volume":"90","author":"Goureau","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.niox.2018.04.010_bib90","first-page":"201","article-title":"Retinal vulnerability to glutamate excitotoxicity in canine glaucoma: induction of neuronal nitric oxide synthase in retinal ganglion cells","volume":"41","author":"Franco-Bourland","year":"1998","journal-title":"Proc. West. Pharmacol. Soc."},{"key":"10.1016\/j.niox.2018.04.010_bib91","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/01.ijg.0000137435.83307.fd","article-title":"Neuronal nitric oxide synthase (nNOS) positive retinal amacrine cells are altered in the DBA\/2NNia mouse, a murine model for angle-closure glaucoma","volume":"13","author":"May","year":"2004","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.niox.2018.04.010_bib92","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12031-012-9943-x","article-title":"Altered expression of nNOS\/NIDD in the retina of a glaucoma model of DBA\/2J mice and the intervention by nNOS inhibition","volume":"51","author":"Chen","year":"2013","journal-title":"J. Mol. Neurosci. MN"},{"key":"10.1016\/j.niox.2018.04.010_bib93","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exer.2004.08.003","article-title":"Immunocytochemical development of the Guinea pig retina","volume":"80","author":"Loeliger","year":"2005","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-9861(19990301)405:1<1::AID-CNE1>3.0.CO;2-U","article-title":"Nitric oxide synthase-containing cells in the retina, pigmented epithelium, choroid, and sclera of the chick eye","volume":"405","author":"Fischer","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.niox.2018.04.010_bib95","first-page":"2884","article-title":"Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure","volume":"40","author":"Shareef","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib96","first-page":"240","article-title":"Nitric oxide synthase-2 in human optic nerve head astrocytes induced by elevated pressure in vitro","volume":"119","author":"Liu","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib97","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00417-003-0638-4","article-title":"Elevation of nitric oxide production in human trabecular meshwork by increased pressure","volume":"241","author":"Schneemann","year":"2003","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib98","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/clinchem\/41.6.892","article-title":"Nitrite and nitrate determinations in plasma: a critical evaluation","volume":"41","author":"Moshage","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.niox.2018.04.010_bib99","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/112067210201200109","article-title":"Decreased nitric oxide production in primary open-angle glaucoma","volume":"12","author":"Doganay","year":"2002","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib100","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/bjo.2003.028357","article-title":"Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma","volume":"88","author":"Galassi","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib101","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000265398","article-title":"Amino acid pattern in human aqueous humor of patients with senile cataract and primary open-angle glaucoma","volume":"17","author":"Hannappel","year":"1985","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.niox.2018.04.010_bib102","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1167\/iovs.11-8420","article-title":"Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma","volume":"53","author":"Javadiyan","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib103","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/archopht.125.4.494","article-title":"Altered nitric oxide system in patients with open-angle glaucoma","volume":"125","author":"Polak","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib104","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exer.2017.05.002","article-title":"Major review: molecular genetics of primary open-angle glaucoma","volume":"160","author":"Liu","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002611","article-title":"Common genetic determinants of intraocular pressure and primary open-angle glaucoma","volume":"8","author":"van Koolwijk","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.niox.2018.04.010_bib106","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00439-013-1349-5","article-title":"Genome-wide association study and meta-analysis of intraocular pressure","volume":"133","author":"Ozel","year":"2014","journal-title":"Hum. Genet."},{"key":"10.1016\/j.niox.2018.04.010_bib107","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/ng.661","article-title":"Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma","volume":"42","author":"Thorleifsson","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.niox.2018.04.010_bib108","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1093\/hmg\/ddr382","article-title":"Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA","volume":"20","author":"Wiggs","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.niox.2018.04.010_bib109","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/13816810.2017.1393830","article-title":"Investigation of CAV1\/CAV2 rs4236601 and CDKN2B-AS1 rs2157719 in primary open-angle glaucoma patients from Brazil","volume":"39","author":"Nunes","year":"2018","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.niox.2018.04.010_bib110","doi-asserted-by":"crossref","first-page":"27837","DOI":"10.1038\/srep27837","article-title":"Ethnic specific association of the CAV1\/CAV2 locus with primary open-angle glaucoma","volume":"6","author":"Rong","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.niox.2018.04.010_bib111","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-4614-1222-9_4","article-title":"Regulation of eNOS in caveolae","volume":"729","author":"Mineo","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.niox.2018.04.010_bib112","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/clinchem\/48.7.989","article-title":"Independent risk factor for moderate to severe internal carotid artery stenosis: T786C mutation of the endothelial nitric oxide synthase gene","volume":"48","author":"Ghilardi","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.niox.2018.04.010_bib113","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.gene.2012.04.047","article-title":"Association of polymorphisms of endothelial nitric oxide synthase (eNOS) gene with the risk of primary open angle glaucoma in a Brazilian population","volume":"502","author":"Magalhaes da Silva","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.niox.2018.04.010_bib114","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1440-1681.1998.tb02138.x","article-title":"Association study of the 5' flanking regions of endothelial-nitric oxide synthase and endothelin-1 genes in familial primary open-angle glaucoma","volume":"25","author":"Tunny","year":"1998","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.niox.2018.04.010_bib115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/ICU.0000000000000245","article-title":"Vascular and autonomic dysregulation in primary open-angle glaucoma","volume":"27","author":"Pasquale","year":"2016","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib116","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ophtha.2011.02.013","article-title":"Initial parafoveal versus peripheral scotomas in glaucoma: risk factors and visual field characteristics","volume":"118","author":"Park","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.niox.2018.04.010_bib117","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/cvr\/cvn068","article-title":"Gender-specific hypertension and responsiveness to nitric oxide in sGC{alpha}1 knockout mice","volume":"79","author":"Buys","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.niox.2018.04.010_bib118","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cardiores.2007.06.002","article-title":"Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation","volume":"76","author":"Nimmegeers","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.niox.2018.04.010_bib119","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-4835(02)00303-2","article-title":"Role of aquaporin water channels in eye function","volume":"76","author":"Verkman","year":"2003","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0014-2999(88)90648-6","article-title":"Direct application of a guanylate cyclase activator lowers intraocular pressure","volume":"147","author":"Nathanson","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.niox.2018.04.010_bib121","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0022-3565(25)11469-9","article-title":"Nitrovasodilators as a new class of ocular hypotensive agents","volume":"260","author":"Nathanson","year":"1992","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.niox.2018.04.010_bib122","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/exer.1994.1199","article-title":"Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys","volume":"58","author":"Schuman","year":"1994","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib123","first-page":"1711","article-title":"Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye","volume":"37","author":"Behar-Cohen","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib124","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.exer.2011.03.001","article-title":"Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2alpha agonist, in preclinical models","volume":"93","author":"Krauss","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib125","doi-asserted-by":"crossref","first-page":"C1378","DOI":"10.1152\/ajpcell.00363.2007","article-title":"NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel","volume":"294","author":"Dismuke","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.niox.2018.04.010_bib126","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1167\/iovs.08-3127","article-title":"Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel","volume":"50","author":"Dismuke","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib127","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1167\/iovs.12-11491","article-title":"Effect of nitric oxide on anterior segment physiology in monkeys","volume":"54","author":"Heyne","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib128","doi-asserted-by":"crossref","first-page":"C1067","DOI":"10.1152\/ajpcell.1995.268.4.C1067","article-title":"Na-K-Cl cotransport regulates intracellular volume and monolayer permeability of trabecular meshwork cells","volume":"268","author":"O'Donnell","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.niox.2018.04.010_bib129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/108076802317233171","article-title":"Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP","volume":"18","author":"Kotikoski","year":"2002","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.niox.2018.04.010_bib130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1076\/ceyr.26.2.119.14511","article-title":"Nitric oxide and cyclic GMP enhance aqueous humor outflow facility in rabbits","volume":"26","author":"Kotikoski","year":"2003","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib131","first-page":"2769","article-title":"Effect of 8-Br cGMP on aqueous humor dynamics in monkeys","volume":"35","author":"Kee","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib132","doi-asserted-by":"crossref","first-page":"8813","DOI":"10.1073\/pnas.82.24.8813","article-title":"Interaction of hydrolysis-resistant analogs of cyclic GMP with the phosphodiesterase and light-sensitive channel of retinal rod outer segments","volume":"82","author":"Zimmerman","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.niox.2018.04.010_bib133","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/S0021-9258(19)39891-6","article-title":"Cellular distribution and differential gene expression of the three alpha subunit isoforms of the Na,K-ATPase in the ocular ciliary epithelium","volume":"265","author":"Ghosh","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2018.04.010_bib134","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1167\/iovs.02-0397","article-title":"Effects of ion transport and channel-blocking drugs on aqueous humor formation in isolated bovine eye","volume":"44","author":"Shahidullah","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib135","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.bjp.0706156","article-title":"Cyclic GMP, sodium nitroprusside and sodium azide reduce aqueous humour formation in the isolated arterially perfused pig eye","volume":"145","author":"Shahidullah","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.niox.2018.04.010_bib136","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.bjp.0706795","article-title":"NO donors inhibit Na,K-ATPase activity by a protein kinase G-dependent mechanism in the nonpigmented ciliary epithelium of the porcine eye","volume":"148","author":"Shahidullah","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.niox.2018.04.010_bib137","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/108076801750295263","article-title":"Intraocular pressure and vascular effects of sodium azide in bovine perfused eye","volume":"17","author":"Millar","year":"2001","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.niox.2018.04.010_bib138","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jcp.24454","article-title":"Nitric oxide regulation of Na, K-ATPase activity in ocular ciliary epithelium involves Src family kinase","volume":"229","author":"Shahidullah","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.niox.2018.04.010_bib139","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11906-012-0320-5","article-title":"Pathophysiology of hypertension in the absence of nitric oxide\/cyclic GMP signaling","volume":"15","author":"Thoonen","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.niox.2018.04.010_bib140","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s00417-002-0559-7","article-title":"Nitric oxide\/guanylate cyclase pathways and flow in anterior segment perfusion","volume":"240","author":"Schneemann","year":"2002","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib141","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1167\/iovs.17-22168","article-title":"The ability of nitric oxide to lower intraocular pressure is dependent on guanylyl cyclase","volume":"58","author":"Muenster","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib142","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1167\/iovs.15-18958","article-title":"The soluble guanylate cyclase stimulator IWP-953 increases conventional outflow facility in mouse eyes","volume":"57","author":"Ge","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib143","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/jamaophthalmol.2015.5601","article-title":"Association of dietary nitrate intake with primary open-angle glaucoma: a prospective analysis from the nurses' health study and health professionals follow-up study","volume":"134","author":"Kang","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib144","first-page":"2515","article-title":"Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide","volume":"35","author":"Wiederholt","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib145","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1167\/iovs.09-5072","article-title":"Endogenous regulation of human Schlemm's canal cell volume by nitric oxide signaling","volume":"51","author":"Ellis","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib146","first-page":"1883","article-title":"Characterization of maxi-K-channels in bovine trabecular meshwork and their activation by cyclic guanosine monophosphate","volume":"38","author":"Stumpff","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib147","first-page":"1404","article-title":"Stimulation of maxi-K channels in trabecular meshwork by tyrosine kinase inhibitors","volume":"40","author":"Stumpff","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib148","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.preteyeres.2010.09.002","article-title":"Use of calcium channel blockers for glaucoma","volume":"30","author":"Araie","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib149","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.RES.62.5.961","article-title":"Cyclic guanosine monophosphate-enhanced sequestration of Ca2+ by sarcoplasmic reticulum in vascular smooth muscle","volume":"62","author":"Twort","year":"1988","journal-title":"Circ. Res."},{"key":"10.1016\/j.niox.2018.04.010_bib150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0002-9394(88)90179-1","article-title":"Sustained reduction of intraocular pressure in humans with the calcium channel blocker verapamil","volume":"105","author":"Abelson","year":"1988","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib151","doi-asserted-by":"crossref","first-page":"21722","DOI":"10.1074\/jbc.M000753200","article-title":"Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle","volume":"275","author":"Sauzeau","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2018.04.010_bib152","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40265-018-0877-7","article-title":"Netarsudil ophthalmic solution 0.02%: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.niox.2018.04.010_bib153","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1152\/physrev.00023.2003","article-title":"Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase","volume":"83","author":"Somlyo","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.niox.2018.04.010_bib154","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.exer.2013.12.012","article-title":"Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility","volume":"120","author":"Dismuke","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib155","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1167\/iovs.14-16015","article-title":"Regulation of endothelin-1-induced trabecular meshwork cell contractility by latanoprostene bunod","volume":"56","author":"Cavet","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib156","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/jcp.24524","article-title":"Regulation of plasticity and fibrogenic activity of trabecular meshwork cells by rho GTPase signaling","volume":"229","author":"Pattabiraman","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.niox.2018.04.010_bib157","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.exer.2007.10.007","volume":"86","author":"Kaufman","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib158","first-page":"34","article-title":"The role of nitric oxide in the intraocular pressure lowering efficacy of latanoprostene bunod: review of nonclinical studies","author":"Cavet","year":"2018","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.niox.2018.04.010_bib159","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1350-9462(99)00015-4","article-title":"The regulation of trabecular meshwork and ciliary muscle contractility","volume":"19","author":"Wiederholt","year":"2000","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib160","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ophtha.2007.10.026","article-title":"Glaucoma is associated with peripheral vascular endothelial dysfunction","volume":"115","author":"Su","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.niox.2018.04.010_bib161","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/heart.85.3.342","article-title":"Endothelial function and nitric oxide: clinical relevance","volume":"85","author":"Vallance","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.niox.2018.04.010_bib162","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace","volume":"113","author":"Forstermann","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2018.04.010_bib163","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1755-3768.2009.01573.x","article-title":"Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma","volume":"88","author":"Fadini","year":"2010","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib164","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.lfs.2012.02.013","article-title":"Endothelin-1 plasma levels and vascular endothelial dysfunction in primary open angle glaucoma","volume":"91","author":"Cellini","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib165","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1350-9462(01)00005-2","article-title":"Blood flow in the optic nerve head and factors that may influence it","volume":"20","author":"Hayreh","year":"2001","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib166","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082351","article-title":"Optic nerve head blood flow autoregulation during changes in arterial blood pressure in healthy young subjects","volume":"8","author":"Boltz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.niox.2018.04.010_bib167","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1350-9462(00)00020-3","article-title":"Endothelium-dependent vasoactive modulation in the ophthalmic circulation","volume":"20","author":"Haefliger","year":"2001","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib168","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1350-9462(01)00014-3","article-title":"Role of nitric oxide in the control of ocular blood flow","volume":"20","author":"Schmetterer","year":"2001","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib169","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/exer.1993.1107","article-title":"L-arginine-derived nitric oxide: a major determinant of uveal blood flow","volume":"57","author":"Deussen","year":"1993","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/jop.1999.15.295","article-title":"Role of nitric oxide in mediating retinal blood flow regulation in cats","volume":"15","author":"Harino","year":"1999","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.niox.2018.04.010_bib171","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/jop.2000.16.55","article-title":"Effect of nitric oxide synthesis inhibition on post-occlusive choroidal blood flow in rats","volume":"16","author":"Koss","year":"2000","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.niox.2018.04.010_bib172","first-page":"784","article-title":"Evidence that nitric oxide is involved in autoregulation in optic nerve head of rabbits","volume":"43","author":"Okuno","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib173","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1167\/iovs.04-1082","article-title":"Time course of changes in optic nerve head circulation after acute reduction in intraocular pressure","volume":"46","author":"Takayama","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib174","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ophtha.2007.04.055","article-title":"Retinal blood flow response to posture change in glaucoma patients compared with healthy subjects","volume":"115","author":"Feke","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.niox.2018.04.010_bib175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajo.2014.03.015","article-title":"Effect of brimonidine on retinal vascular autoregulation and short-term visual function in normal tension glaucoma","volume":"158","author":"Feke","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib176","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1350-9462(97)00006-2","article-title":"Optic nerve blood-flow abnormalities in glaucoma","volume":"17","author":"Flammer","year":"1998","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib177","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/jop.1998.14.473","article-title":"Nitric oxide modulation of retinal, choroidal, and anterior uveal blood flow in newborn piglets","volume":"14","author":"Jacot","year":"1998","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.niox.2018.04.010_bib178","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/jop.2010.0150","article-title":"Enhanced oxygen saturation in optic nerve head of non-human primate eyes following the intravitreal injection of NCX 434, an innovative nitric oxide-donating glucocorticoid","volume":"27","author":"Khoobehi","year":"2011","journal-title":"J. Ocul. Pharmacol. Therapeut. Offic. J. Assoc. Ocular Pharmacol. Therapeut."},{"key":"10.1016\/j.niox.2018.04.010_bib179","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bjo.2007.131789","article-title":"The effect of sildenafil on ocular blood flow","volume":"92","author":"Harris","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib180","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/1097-4652(200009)184:3<409::AID-JCP16>3.0.CO;2-K","article-title":"Molecular mechanism of cGMP-mediated smooth muscle relaxation","volume":"184","author":"Carvajal","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.niox.2018.04.010_bib181","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00061198-199606000-00007","article-title":"Lack of effect of calcium channel blockers on open-angle glaucoma","volume":"5","author":"Liu","year":"1996","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.niox.2018.04.010_bib182","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0002-9394(14)71458-8","article-title":"Calcium channel blockers in the management of low-tension and open-angle glaucoma","volume":"115","author":"Netland","year":"1993","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib183","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.preteyeres.2003.12.001","article-title":"Retinal ischemia: mechanisms of damage and potential therapeutic strategies","volume":"23","author":"Osborne","year":"2004","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib184","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0361-9230(03)00070-4","article-title":"Effectiveness of levobetaxolol and timolol at blunting retinal ischaemia is related to their calcium and sodium blocking activities: relevance to glaucoma","volume":"62","author":"Osborne","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.niox.2018.04.010_bib185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.niox.2018.04.010_bib186","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pneurobio.2005.06.001","article-title":"The physiology and pathophysiology of nitric oxide in the brain","volume":"76","author":"Guix","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.niox.2018.04.010_bib187","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0079-6123(08)61149-8","article-title":"Nitric oxide in the central nervous system","volume":"103","author":"Lipton","year":"1994","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.niox.2018.04.010_bib188","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0896-6273(00)80859-4","article-title":"Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO","volume":"24","author":"Kim","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.niox.2018.04.010_bib189","doi-asserted-by":"crossref","first-page":"9782346","DOI":"10.1155\/2016\/9782346","article-title":"Nitric oxide: a regulator of cellular function in health and disease","volume":"2016","author":"Sobrevia","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.niox.2018.04.010_bib190","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archopht.117.11.1524","article-title":"Nitric oxide mediates excitotoxic and anoxic damage in rat retinal ganglion cells cocultured with astroglia","volume":"117","author":"Morgan","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib191","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.visres.2007.07.011","article-title":"Expression of neuronal nitric oxide synthase in the retina of a rat model of chronic glaucoma","volume":"47","author":"Park","year":"2007","journal-title":"Vis. Res."},{"key":"10.1016\/j.niox.2018.04.010_bib192","doi-asserted-by":"crossref","first-page":"9944","DOI":"10.1073\/pnas.96.17.9944","article-title":"Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma","volume":"96","author":"Neufeld","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.niox.2018.04.010_bib193","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00061198-200206000-00010","article-title":"A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma","volume":"11","author":"Neufeld","year":"2002","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.niox.2018.04.010_bib194","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110397","article-title":"Regulation of nitric oxide production by delta-opioid receptors during glaucomatous injury","volume":"9","author":"Husain","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.niox.2018.04.010_bib195","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/308452a0","article-title":"Prevention of natural motoneurone cell death by dibutyryl cyclic GMP","volume":"308","author":"Weill","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.niox.2018.04.010_bib196","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0006-8993(97)81694-0","article-title":"Cyclic guanosine 3',5'-monophosphate-mediated neuroprotection by nitric oxide in dissociated cultures of rat dorsal root ganglion neurones","volume":"774","author":"Thippeswamy","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.niox.2018.04.010_bib197","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/niox.2001.0316","article-title":"Evidence that nitric oxide-induced synthesis of cGMP occurs in a paracrine but not an autocrine fashion and that the site of its release can be regulated: studies in dorsal root ganglia in vivo and in vitro","volume":"5","author":"Thippeswamy","year":"2001","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2018.04.010_bib198","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000065431","article-title":"Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells","volume":"11","author":"Fiscus","year":"2002","journal-title":"Neurosignals"},{"key":"10.1016\/j.niox.2018.04.010_bib199","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jnr.10483","article-title":"Phosphodiesterase inhibitors are neuroprotective to cultured spinal motor neurons","volume":"71","author":"Nakamizo","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.niox.2018.04.010_bib200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2002.tb04051.x","article-title":"Preconditioning-mediated neuroprotection: role of nitric oxide, cGMP, and new protein expression","volume":"962","author":"Andoh","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib201","doi-asserted-by":"crossref","first-page":"49896","DOI":"10.1074\/jbc.M206177200","article-title":"Nitric oxide protects neuroblastoma cells from apoptosis induced by serum deprivation through cAMP-response element-binding protein (CREB) activation","volume":"277","author":"Ciani","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2018.04.010_bib202","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1046\/j.1471-4159.2002.01080.x","article-title":"Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide","volume":"82","author":"Ciani","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.niox.2018.04.010_bib203","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.jcbfm.9600068","article-title":"Enhanced oxidative stress in iNOS-deficient mice after traumatic brain injury: support for a neuroprotective role of iNOS","volume":"25","author":"Bayir","year":"2005","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.niox.2018.04.010_bib204","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/IJG.0b013e3181752c6f","article-title":"Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration","volume":"18","author":"Karim","year":"2009","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.niox.2018.04.010_bib205","first-page":"688","article-title":"Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action","volume":"42","author":"Mizuno","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib206","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuroscience.2006.02.016","article-title":"Axonal regeneration of cat retinal ganglion cells is promoted by nipradilol, an anti-glaucoma drug","volume":"140","author":"Watanabe","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.niox.2018.04.010_bib207","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1076\/ceyr.24.2.114.8162","article-title":"Neuroprotective effect of nipradilol on axotomized rat retinal ganglion cells","volume":"24","author":"Nakazawa","year":"2002","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.niox.2018.04.010_bib208","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00061198-200206000-00012","article-title":"Neuroprotective effects of nipradilol on purified cultured retinal ganglion cells","volume":"11","author":"Kashiwagi","year":"2002","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.niox.2018.04.010_bib209","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/978-1-4614-3209-8_94","article-title":"Nipradilol promotes axon regeneration through S-nitrosylation of PTEN in retinal ganglion cells","volume":"801","author":"Koriyama","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.niox.2018.04.010_bib210","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1179\/016164110X12681290831243","article-title":"Pharmacological shift of the ambiguous nitric oxide action from neurotoxicity to cyclic GMP-mediated protection","volume":"32","author":"Kohgami","year":"2010","journal-title":"Neurol. Res."},{"key":"10.1016\/j.niox.2018.04.010_bib211","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jnr.21175","article-title":"Cyclic guanosine monophosphate signalling pathway plays a role in neural cell adhesion molecule-mediated neurite outgrowth and survival","volume":"85","author":"Ditlevsen","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.niox.2018.04.010_bib212","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/glia.20105","article-title":"Glial-mediated neuroprotection: evidence for the protective role of the NO-cGMP pathway via neuron-glial communication in the peripheral nervous system","volume":"49","author":"Thippeswamy","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.niox.2018.04.010_bib213","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.neuint.2004.03.021","article-title":"Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation","volume":"45","author":"Contestabile","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.niox.2018.04.010_bib214","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbrc.2017.09.054","article-title":"Both nitric oxide and nitrite prevent homocysteine-induced endoplasmic reticulum stress and subsequent apoptosis via cGMP-dependent pathway in neuronal cells","volume":"493","author":"Jeong","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.niox.2018.04.010_bib215","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9394(14)75085-8","article-title":"Organic nitrate therapy in glaucoma","volume":"90","author":"Wizemann","year":"1980","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib216","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00061198-199300230-00011","article-title":"Nitric oxide and nitrovasodilators in the eye: implications for ocular physiology and glaucoma","volume":"2","author":"Nathanson","year":"1993","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.niox.2018.04.010_bib217","first-page":"820","article-title":"Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension","volume":"56","author":"Kanno","year":"2006","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.niox.2018.04.010_bib218","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ophtha.2016.01.019","article-title":"Latanoprostene bunod 0.024% versus timolol maleate 0.5% in subjects with open-angle glaucoma or ocular hypertension: the APOLLO study","volume":"123","author":"Weinreb","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.niox.2018.04.010_bib219","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ajo.2016.05.012","article-title":"Comparison of latanoprostene bunod 0.024% and timolol maleate 0.5% in open-angle glaucoma or ocular hypertension: the LUNAR study","volume":"168","author":"Medeiros","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib220","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s12325-016-0385-7","article-title":"Long-term safety and efficacy of latanoprostene bunod 0.024% in Japanese subjects with open-angle glaucoma or ocular hypertension: the JUPITER study","volume":"33","author":"Kawase","year":"2016","journal-title":"Adv. Ther."},{"key":"10.1016\/j.niox.2018.04.010_bib221","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s12325-015-0260-y","article-title":"Evaluation of the effect of latanoprostene bunod ophthalmic solution, 0.024% in lowering intraocular pressure over 24 h in healthy Japanese subjects","volume":"32","author":"Araie","year":"2015","journal-title":"Adv. Ther."},{"key":"10.1016\/j.niox.2018.04.010_bib222","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ajo.2016.04.019","article-title":"Efficacy of latanoprostene bunod 0.024% compared with timolol 0.5% in lowering intraocular pressure over 24 hours","volume":"169","author":"Liu","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib223","first-page":"736","article-title":"Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation","volume":"39","author":"Kanno","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib224","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2147\/OPTH.S103985","article-title":"Critical evaluation of latanoprostene bunod in the treatment of glaucoma","volume":"10","author":"Garcia","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib225","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10384-008-0540-z","article-title":"Clinical efficacy of topical nipradilol and timolol on visual field performance in normal-tension glaucoma: a multicenter, randomized, double-masked comparative study","volume":"52","author":"Araie","year":"2008","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib226","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s10384-010-0815-z","article-title":"Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study","volume":"54","author":"Araie","year":"2010","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib227","doi-asserted-by":"crossref","first-page":"652904","DOI":"10.1155\/2011\/652904","article-title":"Retrobulbar hemodynamic effects of nipradilol in normal and normal-tension glaucoma eyes","volume":"2011","author":"Fukukita","year":"2011","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.niox.2018.04.010_bib228","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1167\/iovs.15-17190","article-title":"Intraocular pressure-lowering activity of NCX 470, a novel nitric oxide-donating bimatoprost in preclinical models","volume":"56","author":"Impagnatiello","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib229","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/jop.2009.0120","article-title":"A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma","volume":"26","author":"Borghi","year":"2010","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.niox.2018.04.010_bib230","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1021\/acs.jmedchem.5b00043","article-title":"Synthesis, and evaluation of no-donor containing carbonic anhydrase inhibitors to lower intraocular pressure","volume":"58","author":"Huang","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.niox.2018.04.010_bib231","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/STROKEAHA.113.003606","article-title":"Sildenafil mediates blood-flow redistribution and neuroprotection after neonatal hypoxia-ischemia","volume":"45","author":"Charriaut-Marlangue","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.niox.2018.04.010_bib232","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jocn.2009.03.036","article-title":"Protective effects of tadalafil on experimental spinal cord injury in rats","volume":"17","author":"Serarslan","year":"2010","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.niox.2018.04.010_bib233","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/14767058.2010.492061","article-title":"Effects of sildenafil and tadalafil on ischemia\/reperfusion injury in fetal rat brain","volume":"24","author":"Ozdegirmenci","year":"2011","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.niox.2018.04.010_bib234","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166717","article-title":"Millan JM and Rodrigo R. cGMP-phosphodiesterase inhibition prevents hypoxia-induced cell death activation in porcine retinal explants","volume":"11","author":"Olivares-Gonzalez","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.niox.2018.04.010_bib235","first-page":"1647","article-title":"8-bromo-cyclic GMP lowers intraocular pressure in rabbits","volume":"31","author":"Topical","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib236","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0002-9394(00)00375-5","article-title":"No clinically important effects on intraocular pressure after short-term administration of sildenafil citrate (Viagra)","volume":"129","author":"Yajima","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib237","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1023\/B:INTE.0000031735.45526.1c","article-title":"Acute effects of sildenafil on Humphrey visual field and intraocular pressure","volume":"25","author":"Ermis","year":"2004","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib238","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0002-9394(00)00944-2","article-title":"Effect of sildenafil citrate (Viagra) on the ocular circulation","volume":"131","author":"Grunwald","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib239","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1385\/AO:37:2:085","article-title":"No effects of long-term sildenafil treatment on ocular functions","volume":"37","author":"Oguz","year":"2005","journal-title":"Ann. Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib240","first-page":"4","article-title":"The effect of sildenafil citrate (Viagra) on visual sensitivity","volume":"7","author":"Stockman","year":"2007","journal-title":"J. Vis."},{"key":"10.1016\/j.niox.2018.04.010_bib241","first-page":"177","author":"Center for Drug Evaluation and Research: Study 148-232","year":"1998"},{"key":"10.1016\/j.niox.2018.04.010_bib242","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jns.2007.06.018","article-title":"Anterior ischemic optic neuropathy and stroke with use of PDE-5 inhibitors for erectile dysfunction: cause or coincidence?","volume":"262","author":"Carter","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib243","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00041327-200103000-00006","article-title":"Anterior ischemic optic neuropathy associated with viagra","volume":"21","author":"Cunningham","year":"2001","journal-title":"J. Neuro Ophthalmol."},{"key":"10.1016\/j.niox.2018.04.010_bib244","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-200767010-00006","article-title":"Ocular adverse effects associated with systemic medications : recognition and management","volume":"67","author":"Santaella","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.niox.2018.04.010_bib245","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.ijir.3901544","article-title":"Post-marketing surveillance study of the efficacy and safety of vardenafil among patients with erectile dysfunction in primary care","volume":"19","author":"Kim","year":"2007","journal-title":"Int. J. Impot. Res."},{"key":"10.1016\/j.niox.2018.04.010_bib246","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/j.1939-4640.2002.tb02332.x","article-title":"Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Hellstrom","year":"2002","journal-title":"J. Androl."},{"key":"10.1016\/j.niox.2018.04.010_bib247","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S0022-5347(05)64442-4","article-title":"Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses","volume":"168","author":"Brock","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.niox.2018.04.010_bib248","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-445X.2000.01966.x","article-title":"The Wellcome Prize Lecture. Visual signals in the retina: from photons to synapses","volume":"85","author":"Lagnado","year":"2000","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.niox.2018.04.010_bib249","series-title":"Full Prescribing Information Sildenafil Citrate","author":"ViagraR","year":"2008"},{"key":"10.1016\/j.niox.2018.04.010_bib250","series-title":"Full Prescribing Information Vardenafil","author":"LEVITRAR","year":"2008"},{"key":"10.1016\/j.niox.2018.04.010_bib251","series-title":"Full Prescribing Information Tadalafil","author":"CIALISR","year":"2008"},{"key":"10.1016\/j.niox.2018.04.010_bib252","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1111\/j.1743-6109.2011.02382.x","article-title":"Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature","volume":"8","author":"Azzouni","year":"2011","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.niox.2018.04.010_bib253","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/phar.1592","article-title":"Riociguat: a novel new drug for treatment of pulmonary hypertension","volume":"35","author":"Makowski","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.niox.2018.04.010_bib254","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/annrheumdis-2015-209087","article-title":"Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2","volume":"76","author":"Humbert","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.niox.2018.04.010_bib255","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1167\/iovs.18-23772","article-title":"Novel selective soluble guanylate cyclase activator, MGV354, lowers intraocular pressure in preclinical models, following topical ocular dosing","volume":"59","author":"Prasanna","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.niox.2018.04.010_bib256","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/01.RES.0000184694.03262.6d","article-title":"Explaining the phenomenon of nitrate tolerance","volume":"97","author":"Munzel","year":"2005","journal-title":"Circ. Res."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860318300545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860318300545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T01:16:27Z","timestamp":1751591787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860318300545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":256,"alternative-id":["S1089860318300545"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2018.04.010","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The nitric oxide-guanylate cyclase pathway and glaucoma","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2018.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}